Research Institute of Chemical Diversity (RICD) of the Center of High Technologies “KhimRar” and the Siberian State Medical University, based in Tomsk, have signed an agreement on strategic partnership, the medical and social information agency AMI-TASS reports.
Under plans the partnership will be aimed at development and improvement of the scientific and educational cooperation, achievement of competitive advantages in interdisciplinary science and technological sectors.
The partners will carry out joint applied scientific research in development of innovative medicines based on newest technologies in the field of molecular medicine with further commercialization of their results. Besides, the partners intend to create the single science and educational infrastructure for formation of the new-generation highly qualified specialists in priority development directions. In order to work together under the agreement, the RICD and SibSMU have agreed on mutual use of material and technical base, modern science and research equipment and other resources, needed for scientific and educational projects.
“We hope for prolific cooperation. The Research Institute of Chemical Diversity of the Center of High Technologies “KhimRar” has proved itself to be the leader in development of innovative medicines based on newest technologies. For over 35 years the SibSMU has had medical and biological faculty, providing training for professional scientists; has accumulated advanced expertise in fundamental research in the sector of molecular medicine and development of personalized technologies of diagnostics and treatment of socially-significant diseases. I hope that in partnership with the specialists of the RICD we will get new opportunities for implementing university research, training specialists and participating in development of the national pharmaceutical industry,” Natalya Ryazantseva, the vice-rector of the SibSMU for strategic development and innovative politics, said.
“The Siberian Medical State University is one of the main suppliers of highly qualified specialists for medicine and pharmaceuticals in the country. Synergy of the personnel potential of the SibSMU and business-capacities of the KhimRar will allow us to successfully participate in the national strategy of development of pharmaceutical industry Pharma2020,” Dmitry Kravchenko, the director general of the RICD, added.